Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.00 (+0.04%)
As of: Sep 30, 2026 · 1:48 PM EDT

Pasithea Therapeutics (KTTA) Gross Margin (2022)

Updated

Pasithea Therapeutics (KTTA) recorded Gross Margin of 100.54% in Q4 2022, up 40.10 percentage points from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Gross Margin (2022) Analysis & Trends

For FY2022, Pasithea Therapeutics reported Gross Margin of 76.74%, up 91.43 percentage points from FY2021.

  • Across earlier years, Gross Margin came in at -14.69% in FY2021.
  • Per Business Quant, the preceding three quarters came in at 60.45% (Q3 2022), -11.19% (Q2 2022) and 5.28% (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 68.19%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 74.74%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 73.54%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 78.02%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 83.60%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 85.33%
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 100.54%
Sep 30, 2022 60.45%
Jun 30, 2022 -11.19%
Mar 31, 2022 5.28%
API Access

Pasithea Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=KTTA&period=max&api_key=YOUR_API_KEY